HR 6284 114th Congress House Health

EPI Act

Introduced: September 28, 2016 Introduced by: Smith, Adam Democratic · Washington See on congress.gov

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Sep 28, 2016

Referred to the House Committee on Energy and Commerce.

Sep 28, 2016

Introduced in House

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Plain-English summary Congressional Research Service

Eliminate Price Increases Act of 2016 or the EPI Act

This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the manufacturer of a brand name drug from authorizing or commencing the manufacturing, marketing, selling, or distributing of a generic version of the drug from the time the manufacturer is notified by a generic manufacturer that a generic drug application has been submitted until the expiration or forfeiture of the 180-day exclusivity period granted to the generic manufacturer.

What's happening now September 28, 2016

Referred to the House Committee on Energy and Commerce.

Bill text 1 version

Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 1

Energy and Commerce Committee
House of Representatives

Cite this page click to expand

APA

U.S. Congress. (2026). H.R. 6284: EPI Act. 114th Congress. Open America. https://openamerica.io/bill/114-HR-6284/

MLA

"H.R. 6284: EPI Act." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-6284/.

Bluebook (legal)

H.R. 6284, 114th Cong. (2026), https://openamerica.io/bill/114-HR-6284/.

Markdown link

[H.R. 6284: EPI Act](https://openamerica.io/bill/114-HR-6284/)